Compare HFWA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFWA | QDEL |
|---|---|---|
| Founded | 1927 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 989.5M |
| IPO Year | 1997 | 2022 |
| Metric | HFWA | QDEL |
|---|---|---|
| Price | $28.36 | $12.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $30.50 | $28.25 |
| AVG Volume (30 Days) | 265.8K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | ★ 58.06 | 45.35 |
| EPS | ★ 0.90 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $45.85 | $3.51 |
| Revenue Next Year | $7.83 | $3.86 |
| P/E Ratio | $32.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.32 | $9.92 |
| 52 Week High | $31.25 | $35.58 |
| Indicator | HFWA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 36.54 |
| Support Level | $26.53 | $11.37 |
| Resistance Level | $28.52 | $12.85 |
| Average True Range (ATR) | 0.42 | 0.81 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 3.13 | 2.17 |
Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.